Compare DOUG & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOUG | PROF |
|---|---|---|
| Founded | 1911 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Building operators | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.1M | 230.4M |
| IPO Year | N/A | N/A |
| Metric | DOUG | PROF |
|---|---|---|
| Price | $2.66 | $7.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 533.5K | 232.3K |
| Earning Date | 03-09-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,030,928,000.00 | $14,297,000.00 |
| Revenue This Year | $17.61 | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.67 | ★ 67.94 |
| 52 Week Low | $1.48 | $3.76 |
| 52 Week High | $3.20 | $8.95 |
| Indicator | DOUG | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 47.05 |
| Support Level | $2.51 | $7.59 |
| Resistance Level | $2.78 | $8.26 |
| Average True Range (ATR) | 0.15 | 0.58 |
| MACD | 0.03 | -0.11 |
| Stochastic Oscillator | 49.33 | 12.92 |
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.